OWC Pharmaceutical Research Corp. — Net Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/fe68c515-f624-4d60-ae8c-e80785ed623a/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2018 | $-10.3M | 2018-01-01 – 2018-12-31 | evidence 0001493152-19-004459 |
| FY 2017 | $-4.6M | 2017-01-01 – 2017-12-31 | evidence 0001493152-19-004459 |
| FY 2016 | $-2.3M | 2016-01-01 – 2016-12-31 | evidence 0001493152-17-004033 |
| FY 2015 | $-1.7M | 2015-01-01 – 2015-12-31 | evidence 0001295345-16-000509 |
| FY 2014 | $-5.1M | 2014-01-01 – 2014-12-31 | evidence 0001295345-15-000082 |
| FY 2013 | $-1.3M | 2008-03-07 – 2014-03-31 | evidence 0001295345-14-000094 |
| FY 2012 | $-83.7k | 2012-01-01 – 2012-12-31 | evidence 0001295345-14-000048 |
| FY 2011 | $-78.5k | 2011-01-01 – 2011-12-31 | evidence 0001295345-13-000053 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
OWC Pharmaceutical Research Corp. — all facts · Revenue · Operating Income